Ceva Animal Health launched Vectormune HVT-LT, a vector vaccine, to the poultry industry at the 2012 International Poultry Exposition in Atlanta. 

According to Ceva, this vector vaccine protects against both Infectious Laryngotracheitis and Marek’s Disease. Vectormune HVT-LT can be administered in the hatchery, in ovo, or at day of age to provide lifelong protection.